Analysis of European Biotech Companies on the Stock Markets
The BIOCOM report “Analysis of European Biotech Companies on the Stock Markets: US vs Europe” provides a complete overview of the current European public biotech sector. Ever since 2012, it covers all IPOs, follow-on financings, and secondary listings on all major stock market centres in Europe, as well as on Nasdaq.
Do you want to know more? Are you ready to become part of the European biotech picture? Contact us now: